287 related articles for article (PubMed ID: 34587428)
1. Understanding Nanotechnology in the Treatment of Oral Cancer: A Comprehensive Review.
Taneja N; Alam A; Patnaik RS; Taneja T; Gupta S; K SM
Crit Rev Ther Drug Carrier Syst; 2021; 38(6):1-48. PubMed ID: 34587428
[TBL] [Abstract][Full Text] [Related]
2. Nanotechnology-based drug delivery systems for treatment of oral cancer: a review.
Calixto G; Bernegossi J; Fonseca-Santos B; Chorilli M
Int J Nanomedicine; 2014; 9():3719-35. PubMed ID: 25143724
[TBL] [Abstract][Full Text] [Related]
3. Insight on nano drug delivery systems with targeted therapy in treatment of oral cancer.
Vyas K; Rathod M; Patel MM
Nanomedicine; 2023 Apr; 49():102662. PubMed ID: 36746272
[TBL] [Abstract][Full Text] [Related]
4. Oral Squamous Cell Carcinoma: Current Treatment Strategies and Nanotechnology-Based Approaches for Prevention and Therapy.
Gharat SA; Momin M; Bhavsar C
Crit Rev Ther Drug Carrier Syst; 2016; 33(4):363-400. PubMed ID: 27910740
[TBL] [Abstract][Full Text] [Related]
5. Update on Nanotechnology-based Drug Delivery Systems in Cancer Treatment.
Ho BN; Pfeffer CM; Singh ATK
Anticancer Res; 2017 Nov; 37(11):5975-5981. PubMed ID: 29061776
[TBL] [Abstract][Full Text] [Related]
6. Recent advances of nano-drug delivery system in oral squamous cell carcinoma treatment.
Zhu Y; Wen LM; Li R; Dong W; Jia SY; Qi MC
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9445-9453. PubMed ID: 31773682
[TBL] [Abstract][Full Text] [Related]
7. Review of the Role of Nanotechnology in Overcoming the Challenges Faced in Oral Cancer Diagnosis and Treatment.
Umapathy VR; Natarajan PM; Swamikannu B
Molecules; 2023 Jul; 28(14):. PubMed ID: 37513267
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a New Hydroxyapatite Nanoparticle as a Drug Delivery System to Oral Squamous Cell Carcinoma Cells.
Murata T; Kutsuna T; Kurohara K; Shimizu K; Tomeoku A; Arai N
Anticancer Res; 2018 Dec; 38(12):6715-6720. PubMed ID: 30504381
[TBL] [Abstract][Full Text] [Related]
9. Nanomedicine, an emerging therapeutic strategy for oral cancer therapy.
Marcazzan S; Varoni EM; Blanco E; Lodi G; Ferrari M
Oral Oncol; 2018 Jan; 76():1-7. PubMed ID: 29290280
[TBL] [Abstract][Full Text] [Related]
10. Oral and IV dosages of doxorubicin-methotrexate loaded- nanoparticles inhibit progression of oral cancer by down- regulation of matrix Methaloproteinase 2 expression in vivo.
Abbasi MM; Jahanban-Esfahlan R; Monfaredan A; Seidi K; Hamishehkar H; Khiavi MM
Asian Pac J Cancer Prev; 2014; 15(24):10705-11. PubMed ID: 25605162
[TBL] [Abstract][Full Text] [Related]
11. A Mini-Review on Nano Technology in the Tumour Targeting Strategies: Drug Delivery to Cancer Cells.
Kaur L; Sohal HS; Kaur M; Malhi DS; Garg S
Anticancer Agents Med Chem; 2020; 20(17):2012-2024. PubMed ID: 32753024
[TBL] [Abstract][Full Text] [Related]
12. Current Trends of Targeted Drug Delivery for Oral Cancer Therapy.
Zhang M; Liang J; Yang Y; Liang H; Jia H; Li D
Front Bioeng Biotechnol; 2020; 8():618931. PubMed ID: 33425881
[TBL] [Abstract][Full Text] [Related]
13. Advances and Implications in Nanotechnology for Lung Cancer Management.
Sarkar S; Osama K; Jamal QMS; Kamal MA; Sayeed U; Khan MKA; Siddiqui MH; Akhtar S
Curr Drug Metab; 2017; 18(1):30-38. PubMed ID: 27842486
[TBL] [Abstract][Full Text] [Related]
14. Current Novel Drug Deliveries for Oral Cancer: A Chronotherapeutic Approach.
Sutar KP; Shirkoli NS; Sutar PS; Kurangi BK; Dandagi PM; Masareddy R
Curr Drug Deliv; 2023; 20(3):237-249. PubMed ID: 35400343
[TBL] [Abstract][Full Text] [Related]
15. A cell-targeted chemotherapeutic nanomedicine strategy for oral squamous cell carcinoma therapy.
Wang ZQ; Liu K; Huo ZJ; Li XC; Wang M; Liu P; Pang B; Wang SJ
J Nanobiotechnology; 2015 Oct; 13():63. PubMed ID: 26427800
[TBL] [Abstract][Full Text] [Related]
16. PEGylated doxorubicin nanoparticles mediated by HN-1 peptide for targeted treatment of oral squamous cell carcinoma.
Wang Y; Wan G; Li Z; Shi S; Chen B; Li C; Zhang L; Wang Y
Int J Pharm; 2017 Jun; 525(1):21-31. PubMed ID: 28412450
[TBL] [Abstract][Full Text] [Related]
17. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
18. Design strategy and research progress of multifunctional nanoparticles in lung cancer therapy.
Min SH; Lei W; Jun CJ; Yan ZS; Guang YX; Tong Z; Yong ZP; Hui LZ; Xing H
Expert Opin Investig Drugs; 2023; 32(8):723-739. PubMed ID: 37668152
[TBL] [Abstract][Full Text] [Related]
19. Nanotechnology-based drug delivery systems for enhanced diagnosis and therapy of oral cancer.
Ding Z; Sigdel K; Yang L; Liu Y; Xuan M; Wang X; Gu Z; Wu J; Xie H
J Mater Chem B; 2020 Oct; 8(38):8781-8793. PubMed ID: 33026383
[TBL] [Abstract][Full Text] [Related]
20. Application of nanocarrier-based drug delivery system in treatment of oral cancer.
Sah AK; Vyas A; Suresh PK; Gidwani B
Artif Cells Nanomed Biotechnol; 2018 Jun; 46(4):650-657. PubMed ID: 28880679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
